リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh

Sarker Md Habibur Rahman 広島大学

2021.11.25

概要

Background: Studies have labelled chronic kidney disease (CKD) among the adult population in urban Bangladesh. To address knowledge gaps on CKD, we aimed to generate data on prevalence, health and nutrition of CKD individuals living in rural and peri-urban Bangladesh.

Methods: Participants were recruited from the Mirzapur Demographic Surveillance System by age-stratified random sampling. We screened participants by measuring serum creatinine and urine albumin to creatinine ratio, and collected socio-demographic, lifestyles and health information (phase I). After 3months (phase II), we repeated the urine and blood tests as per the Kidney Disease Outcomes Quality Initiative guidelines. The glomerular filtration rate was calculated using the CKD Epidemiology Collaboration equation.

Results: Among 928 participants, 872 completed the study. In phase I, probable CKD cases were 281 (32.2%); in phase II, confirmed cases were 192 (22.0%) (stage 1, 4.0%; stage 2, 11.8%; stage 3, 5.5%; stage 4, 0.6%; stage 5, 0.1%). In multivariable analysis, associated factors for prevalent CKD included aged ⩾60years [adjusted odds ratio (aOR) 5.02; 95% confidence interval (CI) 1.85–13.65], hypertension (aOR 3.08; 95% CI 2.07–4.59), diabetes (aOR 2.52; 95% CI 1.60–3.96), presence of red blood cell in urine (aOR 3.20; 95% CI 1.71–5.98) and anemia (aOR 2.50; 95% CI 1.63–3.84).

Conclusions: This is the first ever research on CKD prevalence in rural and peri-urban Bangladesh and recorded about 22%, which is higher than urban settings. Monitoring systems are needed to evaluate the overall burden and to mitigate risk factors with an emphasis on the rural and peri-urban population.

Keywords: Bangladesh, chronic kidney disease, health and nutritional status, prevalence, rural and peri-urban

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl 2011 2017; 7: 71–87.

2. Luyckx VA, Tonelli M and Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull WHO 2018; 96: 414–422D.

3. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709–733.

4. Hall ME, do Carmo JM, da Silva AA, et al. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 2014; 7: 75–88.

5. Wouters OJ, O’Donoghue DJ, Ritchie J, et al. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 2015; 11: 491–502.

6. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015; 385: 1975–1982.

7. Luyckx VA, Naicker S and McKee M. Equity and economics of kidney disease in sub-Saharan Africa. Lancet 2013; 382: 103–104.

8. Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 2017; 390: 1888–1917.

9. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260–272.

10. Abraham G, Varughese S, Thandavan T, et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J 2016; 9: 135–141.

11. Anand S, Khanam MA, Saquib J, et al. High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Global Health 2014; 10: 9.

12. Huda MN, Alam KS and Harun UR. Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population. Int J Nephrol 2012; 2012: 267329.

13. Fatema K, Abedin Z, Mansur A, et al. Screening for chronic kidney diseases among an adult population. Saudi J Kidney Dis Transpl 2013; 24: 534–541.

14. Hasan M, Kashem M, Rahman M, et al. Prevalence of chronic kidney disease (CKD) and identification of associated risk factors among rural population by mass screening. Community Based Med J 2013; 1: 20–26.

15. Saha SK, Ahmed ZB, Modak JK, et al. Group B Streptococcus among pregnant women and newborns in Mirzapur, Bangladesh: colonization, vertical transmission, and serotype distribution. J Clin Microbiol 2017; 55: 2406–2412.

16. Das SK, Nasrin D, Ahmed S, et al. Health care-seeking behavior for childhood diarrhea in Mirzapur, rural Bangladesh. Am J Trop Med Hyg 2013; 89: 62–68.

17. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63: 713–735.

18. Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS One 2016; 11: e0158765.

19. Fottrell E, Ahmed N, Shaha SK, et al. Distribution of diabetes, hypertension and non- communicable disease risk factors among adults in rural Bangladesh: a cross-sectional survey. BMJ Glob Health 2018; 3: e000787.

20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), Expert Panel On Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

21. Sultana T, Karim MN, Ahmed T, et al. Assessment of under nutrition of Bangladeshi adults using anthropometry: can body mass index be replaced by mid-upper-arm circumference? PLoS One 2015; 10: e0121456.

22. Huque R, Zaman MM, Huq SM, et al. Smokeless tobacco and public health in Bangladesh. Indian J Public Health 2017; 61: S18–S24.

23. Hasan M, Sutradhar I, Gupta RD, et al. Prevalence of chronic kidney disease in South Asia: a systematic review. BMC Nephrol 2018; 19: 291.

24. Das SK, Afsana SM, Elahi SB, et al. Renal insufficiency among urban populations in Bangladesh: a decade of laboratory-based observations. PLoS One 2019; 14: e0214568.

25. Ferguson R, Leatherman S, Fiore M, et al. Prevalence and risk factors for CKD in the general population of Southwestern Nicaragua. J Am Soc Nephrol 2020; 31: 1585–1593.

26. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1–12.

27. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621–630.

28. Varma PP. Prevalence of chronic kidney disease in India: where are we heading? Indian J Nephrol 2015; 25: 133–135.

29. Mallappallil M, Friedman EA, Delano BG, et al. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond Engl) 2014; 11: 525–535.

30. Rai PK, Rai P, Bhat RG, et al. Chronic kidney disease among middle-aged and elderly population: a cross-sectional screening in a hospital camp in Varanasi, India. Saudi J Kidney Dis Transpl 2019; 30: 795–802.

31. Singh AK, Farag YM, Mittal BV, et al. Epidemiology and risk factors of chronic kidney disease in India: results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol 2013; 14: 114.

32. Cao Y, Li W, Yang G, et al. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990–1991 and 2009–2010. Int Urol Nephrol 2012; 44: 1269–1276.

33. Biswas T, Islam A, Rawal LB, et al. Increasing prevalence of diabetes in Bangladesh: a scoping review. Public Health 2016; 138: 4–11.

34. Chowdhury MZI, Rahman M, Akter T, et al. Hypertension prevalence and its trend in Bangladesh: evidence from a systematic review and meta-analysis. Clin Hypertens 2020; 26: 10.

35. Dowling TC. Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am J Health Syst Pharm 2007; 64: S3–S7. quiz S23–S25. 2007/07/13.

36. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004; 20: 1501–1510.

37. Astor BC, Muntner P, Levin A, et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2002; 162: 1401–1408.

38. Hsu CY, McCulloch CE and Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13: 504–510.

39. Orlandi PF, Fujii N, Roy J, et al. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol 2018; 19: 150.

40. Glassock RJ and Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009; 120: 419–428.

41. Jonsson AJ, Lund SH, Eriksen BO, et al. The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds. Kidney Int 2020; 98: 1286–1295.

42. Delanaye P, Jager KJ, Bökenkamp A, et al. CKD: a call for an age-adapted definition. J Am Soc Nephrol 2019; 30: 1785–1805.

43. Guligowska A, Corsonello A, Pigłowska M, et al. Association between kidney function, nutritional status and anthropometric measures in older people: the screening for CKD among Older People across Europe (SCOPE) study. BMC Geriatr 2020; 20: 366.

44. Hurt LS, Ronsmans C and Saha S. Effects of education and other socioeconomic factors on middle age mortality in rural Bangladesh. J Epidemiol Community Health 2004; 58: 315–320.

45. Mikolasevic I, Žutelija M, Mavrinac V, et al. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis 2017; 10: 35–45.

46. Cao X, Zhou J, Yuan H, et al. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol 2015; 16: 85.

47. Park S, Lee S, Kim Y, et al. Short or long sleep duration and CKD: a Mendelian randomization study. J Am Soc Nephrol 2020; 31: 2937–2947.

48. Russcher M, Koch B, Nagtegaal E, et al. The role of melatonin treatment in chronic kidney disease. Front Biosci (Landmark edition) 2012; 17: 2644–2656.

49. Yacoub R, Habib H, Lahdo A, et al. Association between smoking and chronic kidney disease: a case control study. BMC Public Health 2010; 10: 731.

50. Xia J, Wang L, Ma Z, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant 2017; 32: 475–487.

51. Wang M, Yu SY, Lv ZT, et al. Betel nut chewing and the risk of chronic kidney disease: evidence from a meta-analysis. Int Urol Nephrol 2018; 50: 1097–1104.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る